Tumor-induced osteomalacia: a case report

J Med Case Rep. 2022 Jan 12;16(1):22. doi: 10.1186/s13256-021-03220-7.

Abstract

Background: Tumor-induced osteomalacia is a rare, acquired paraneoplastic syndrome, including hypophosphatemia, high serum alkaline phosphatase, reduced active vitamin D, suboptimal bone mineral density, bone pain, fragility fractures, and muscle weakness.

Case presentation: We report a case of 74-year-old male of mixed ancestry with hypophosphatemia resistant to treatment despite optimal compliance, associated with profound reduction of bone mineral density and multiple nontraumatic fractures, including bilateral rib fractures, lower-thoracic (T11, T12) vertebrae, and two fractures involving the surgical and anatomical neck of the right humerus. We discuss an approach to identifying the underlying cause of hypophosphatemia associated with fragility fractures, and options for management of this rare condition.

Conclusion: Although rare, tumor-induced osteomalacia can be diagnosed if a logical stepwise approach is implemented. Surgery could be curative if the tumor is properly located and is resectable.

Keywords: Fibroblast growth factor-23; Hypophosphatemia; Osteomalacia; Tumor-induced osteomalacia.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Fibroblast Growth Factors
  • Humans
  • Hypophosphatemia* / etiology
  • Male
  • Neoplasms, Connective Tissue* / complications
  • Neoplasms, Connective Tissue* / diagnostic imaging
  • Neoplasms, Connective Tissue* / surgery
  • Osteomalacia* / diagnostic imaging
  • Osteomalacia* / etiology
  • Paraneoplastic Syndromes* / etiology

Substances

  • Fibroblast Growth Factors

Supplementary concepts

  • Oncogenic osteomalacia